Radiomics in immuno-oncology

Z. Bodalal, I. Wamelink, S. Trebeschi, R. G.H. Beets-Tan*

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

Abstract

With the ongoing advances in imaging techniques, increasing volumes of anatomical and functional data are being generated as part of the routine clinical workflow. This surge of available imaging data coincides with increasing research in quantitative imaging, particularly in the domain of imaging features. An important and novel approach is radiomics, where high-dimensional image properties are extracted from routine medical images. The fundamental principle of radiomics is the hypothesis that biomedical images contain predictive information, not discernible to the human eye, that can be mined through quantitative image analysis. In this review, a general outline of radiomics and artificial intelligence (AI) will be provided, along with prominent use cases in immunotherapy (e.g. response and adverse event prediction) and targeted therapy (i.e. radiogenomics). While the increased use and development of radiomics and AI in immuno-oncology is highly promising, the technology is still in its early stages, and different challenges still need to be overcome. Nevertheless, novel AI algorithms are being constructed with an ever-increasing scope of applications.
Original languageEnglish
Article number100028
JournalImmuno-Oncology and Technology
Volume9
DOIs
Publication statusPublished - 1 Mar 2021

Keywords

  • artificial intelligence
  • imaging markers
  • immunotherapy
  • precision medicine
  • radiogenomics
  • radiomics

Fingerprint

Dive into the research topics of 'Radiomics in immuno-oncology'. Together they form a unique fingerprint.

Cite this